These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 33639045
1. Effect of vitamin K2 and vitamin D3 on bone mineral density in children with acute lymphoblastic leukemia: a prospective cohort study. Solmaz I, Ozdemir MA, Unal E, Abdurrezzak U, Muhtaroglu S, Karakukcu M. J Pediatr Endocrinol Metab; 2021 Apr 27; 34(4):441-447. PubMed ID: 33639045 [Abstract] [Full Text] [Related]
2. Therapeutic effects of systemic vitamin k2 and vitamin d3 on gingival inflammation and alveolar bone in rats with experimentally induced periodontitis. Aral K, Alkan BA, Saraymen R, Yay A, Şen A, Önder GÖ. J Periodontol; 2015 May 27; 86(5):666-73. PubMed ID: 25569194 [Abstract] [Full Text] [Related]
3. OPG/RANK/RANKL Axis in Egyptian Children With Acute Lymphoblastic Leukemia After Maintenance Therapy: Relationship to Bone Mineral and Vitamin D Status. Hablas NM, Keshk WA. J Pediatr Hematol Oncol; 2023 Aug 01; 45(6):e733-e738. PubMed ID: 37494610 [Abstract] [Full Text] [Related]
4. Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts. Sanguineti R, Monacelli F, Parodi A, Furfaro AL, Borghi R, Pacini D, Pronzato MA, Odetti P, Molfetta L, Traverso N. J Biol Regul Homeost Agents; 2016 Aug 01; 30(3):713-726. PubMed ID: 27655488 [Abstract] [Full Text] [Related]
5. Protective effect of vitamins K2 and D3 on prednisolone-induced loss of bone mineral density in the lumbar spine. Yonemura K, Fukasawa H, Fujigaki Y, Hishida A. Am J Kidney Dis; 2004 Jan 01; 43(1):53-60. PubMed ID: 14712427 [Abstract] [Full Text] [Related]
6. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets. Zhao L, Li M, Sun H. J Anim Physiol Anim Nutr (Berl); 2019 Jul 01; 103(4):1224-1232. PubMed ID: 31062421 [Abstract] [Full Text] [Related]
7. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women. Yasui T, Miyatani Y, Tomita J, Yamada M, Uemura H, Miura M, Irahara M. Gynecol Endocrinol; 2006 Aug 01; 22(8):455-9. PubMed ID: 17012108 [Abstract] [Full Text] [Related]
8. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. Morishita M, Nagashima M, Wauke K, Takahashi H, Takenouchi K. J Rheumatol; 2008 Mar 01; 35(3):407-13. PubMed ID: 18260178 [Abstract] [Full Text] [Related]
9. Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio. Zheng H, Qi S, Chen C. Molecules; 2018 Sep 19; 23(9):. PubMed ID: 30235836 [Abstract] [Full Text] [Related]
10. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). Sasaki N, Kusano E, Takahashi H, Ando Y, Yano K, Tsuda E, Asano Y. J Bone Miner Metab; 2005 Sep 19; 23(1):41-7. PubMed ID: 15616893 [Abstract] [Full Text] [Related]
11. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway. He XF, Zhang L, Zhang CH, Zhao CR, Li H, Zhang LF, Tian GF, Guo MF, Dai Z, Sui FG. Bosn J Basic Med Sci; 2017 Nov 20; 17(4):295-301. PubMed ID: 29055350 [Abstract] [Full Text] [Related]
12. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia. Gunes AM, Can E, Saglam H, Ilçöl YO, Baytan B. J Pediatr Hematol Oncol; 2010 Apr 20; 32(3):e102-7. PubMed ID: 20216235 [Abstract] [Full Text] [Related]
13. Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells (PBMC) after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. Stuss M, Rieske P, Cegłowska A, Stêpień-Kłos W, Liberski PP, Brzeziańska E, Sewerynek E. J Clin Endocrinol Metab; 2013 May 20; 98(5):E1007-11. PubMed ID: 23543663 [Abstract] [Full Text] [Related]
17. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol. Inoue T, Sugiyama T, Matsubara T, Kawai S, Furukawa S. Endocr J; 2001 Feb 20; 48(1):11-8. PubMed ID: 11403096 [Abstract] [Full Text] [Related]